Jay Olson; Analyst; Oppenheimer & Co., Inc. Welcome to the Viking Therapeutics' first-quarter 2025 financial results conference call. (Operator Instructions) As a reminder, this conference call is ...

Monopoly Go players who need extra tokens to progress through the latest Adventure Club event should give Viking Voyage a go. This new Monopoly Go event launched alongside the return of the ...

Viking Ocean Cruises and Seabourn Cruise Line are very different cruise providers, even though both fall into the luxury cruise category. Seabourn is considered an ultra-luxury brand with smaller ...

Viking soared more than 100% in one trading session last year on positive clinical trial news. The stock has since given up those gains, but its weight loss drug program continues to advance and ...

More than 30 people got sick in a gastrointestinal illness outbreak on a Viking cruise. Among 355 guests on its Viking Polaris ship, 28 reported being ill during its current voyage, along with ...

LOS ANGELES--(BUSINESS WIRE)--Viking® (www.viking.com) (NYSE: VIK) and Fincantieri today announced details of the Viking Libra, the world’s first hydrogen-powered cruise ship, capable of ...

Viking Therapeutics VKTX is set to give its latest quarterly earnings report on Wednesday, 2025-04-23. Here's what investors need to know before the announcement. Analysts estimate that Viking ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

In this article, we are going to take a look at where Viking Holdings Ltd. (NYSE:VIK) stands against other stocks that lead rally amid market bloodbath. The stock market took a battering anew on ...

The CDC noted that the outbreak occurred on the Viking Polaris cruise ship, which departed on Friday, April 11 Kimberlee Speakman is a digital writer at PEOPLE. She has been working at PEOPLE ...

The annual snapshot details the most commonly forgotten items left behind in rides and unique items, including a Viking drinking horn, a live turtle, and even Ozempic. “From wayward mannequin ...

Goldman Sachs analyst Richard Law initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $30 price target The company’s lead asset, VK2735, is a dual GLP-1/GIP agonist being ...